Antioxidant <i>N</i> ‐acetylcysteine as an intervention for neuropsychiatric symptoms in individuals with vascular mild cognitive impairment
The findings support NAC as a potential treatment for apathy and emotional dysregulation in individuals with vMCI and at risk of dementia, thereby reducing associated burdens.
Authors
- Yejin Kang (ORCID: https://orcid.org/0000-0002-3436-1846)
- Kate Survilla
- Alex Kiss
- Damien Gallagher (ORCID: https://orcid.org/0000-0001-8952-3200)
- Ethan Mah
- Alan Peng
- Danielle Fernanda Fernandes. Vieira
- Joel Ramirez (ORCID: https://orcid.org/0000-0002-5582-1776)
- P. OH
- Zahinoor Ismail
- Walter Swardfager
- Krista L Lanctôt
- Nathan Herrmann
- Sandra E. Black
Institutions
- Sunnybrook Health Science Centre (CA)
- University Health Network (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Toronto Rehabilitation Institute (CA)
- Health Sciences Centre (CA)
- Ontario Brain Institute (CA)
- Sunnybrook Hospital (CA)
- Sunnybrook Research Institute
- Hotchkiss Brain Institute (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_106844
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00